Recursion Pharmaceuticals, Inc. Class A Common Stock

RXRX US75629V1044

💰
Capitalization
Small-cap

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.

Annual Performance 1
2021 2022 2023 2024 2025
-45% -57% 31% -32% 0%
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
130
🙍
Insiders
9
Person Price Shares Total Published Completed
Gibson Christopher
CEO
4.76
USD
100,000
Sold
476,000
USD
25/09/2025 25/09/2025
Gibson Christopher
CEO
4.71
USD
100,000
Sold
471,000
USD
10/09/2025 10/09/2025
Gibson Christopher
CEO
4.84
USD
100,000
Sold
484,000
USD
26/08/2025 26/08/2025
Khan Najat
SR OFF
5.52
USD
36,599
Sold
202,173
USD
15/08/2025 18/08/2025
Gibson Christopher
CEO
5.28
USD
100,000
Sold
528,000
USD
11/08/2025 11/08/2025
Gibson Christopher
CEO
5.28
USD
17,875
Sold
94,380
USD
11/08/2025 11/08/2025
Gibson Christopher
CEO
5.28
USD
500,300
Sold
2,641,584
USD
11/08/2025 11/08/2025
Gibson Christopher
CEO
6.04
USD
138,574
Sold
836,987
USD
27/03/2025 27/03/2025
Gibson Christopher
CEO
6.37
USD
20,000
Sold
127,400
USD
05/03/2025 06/03/2025
Gibson Christopher
CEO
6.58
USD
20,000
Sold
131,600
USD
05/03/2025 05/03/2025

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include Recursion Pharmaceuticals, Inc. Class A Common Stock to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Historical Performance
1M 3M 6M 1Y 3Y 5Y All Time
14% -9% -35% -1% 0% 0% -77%
Last 52W Low 52W High All-Time Low All-Time High β
4.98 3.97 10.87 3.97 41.33
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Gibson Christopher 52 14,825,399.49 285,103.84 01/11/2023 25/09/2025
Secora Michael 26 3,939,786.92 151,530.27 14/11/2023 13/11/2024
Borgeson Blake 30 3,370,275.33 112,342.51 31/10/2023 12/11/2024
Virani Shafique 3 486,720.00 162,240.00 15/11/2023 16/01/2024
Marriott Tina 10 471,820.39 47,182.04 22/02/2024 24/10/2024
Li Dean Y 2 396,213.83 198,106.92 09/01/2024 09/01/2024
Larson Tina Marriott 5 221,464.70 44,292.94 26/10/2023 25/01/2024
Khan Najat 1 202,172.88 202,172.88 18/08/2025 18/08/2025
Dar Zavain 1 181,269.00 181,269.00 14/12/2023 14/12/2023

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Connected Companies 3
Name ISIN Ticker
MERCK & CO., INC. US58933Y1055 MRK

3 the firms where the current insiders have executed transactions.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.